Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Veritas Intercontinental Completes €5M Series B Financing Round

Veritas Intercontinental Completes €5M Series B Financing Round

Oct 15, 2020
|
staff reporter

NEW YORK – Preventive genomics medicine company Veritas Intercontinental said on Thursday that it has completed a €5 million ($5.8 million) Series B financing round.

The round was led by Charme Capital Partners and Amadeus Capital Partners, who have invested in the Veritas Genetics spinoff firm since it was founded in 2018. They were joined in the Series B round by Stemar Capital Partners and entrepreneur Graham Snudden.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Funds Sought for Vaccine Distribution

The Washington Post reports that US states and territories are seeking more funding for the distribution of SARS-CoV-2 vaccines.

Virus Variant From Spain Now Across UK

The strain now accounts for about 80 percent of cases in Wales and Scotland, and about half of cases in England, the Guardian reports.

Unexpected Loss

A new study suggests that using CRISPR to edit human embryonic DNA can lead to the loss of whole chromosomes, as the Associated Press reports.

Science Papers on Long Human-Canine Relationship, Population History of Early East Asians, More

In Science this week: ancient dog genomes highlight long ties with humans, genomic analysis of 40,000-year-old early East Asian individual, and more.

What's Popular?

In Business News

  1. Illumina Q3 Revenues Down 12 Percent

  2. Qiagen, Phase Genomics Ink US Licensing Agreement for Hi-C Sequencing Technloogy

  3. Bio-Rad Q3 Revenues Jump 15 Percent

  4. Opko Health Q3 Revenues Up 87 Percent

  5. Biocartis, Exact Sciences Terminate Oncotype DX Agreement

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.